|
Index of reports
> Cases with Dyspnoea (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Naglazyme (Galsulfase) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Naglazyme side effects in female
Reported by a individual with unspecified qualification from Brazil on 2012-08-17
Patient: female
Reactions: Dyspnoea, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naglazyme
Possible Naglazyme side effects in female
Reported by a individual with unspecified qualification from Brazil on 2012-05-07
Patient: female
Reactions: Dyspnoea, Oedema Peripheral
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naglazyme
Possible Naglazyme side effects in male
Reported by a individual with unspecified qualification from Brazil on 2012-02-03
Patient: male, weighing 26.0 kg (57.2 pounds)
Reactions: Nasopharyngitis, Dyspnoea, Cardiopulmonary Failure, Tachycardia, Acute Myocardial Infarction, Hypertension, Oxygen Saturation Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Naglazyme
Other drugs received by patient: Unspecified Corticoids
Possible Naglazyme side effects in male
Reported by a pharmacist from Brazil on 2012-01-23
Patient: male, weighing 26.0 kg (57.2 pounds)
Reactions: Dyspnoea, Nasopharyngitis, Tachycardia, Cardiopulmonary Failure, Acute Myocardial Infarction, Hypertension, Oxygen Saturation Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Naglazyme
Other drugs received by patient: Unspecified Corticoids
Possible Naglazyme side effects in male
Reported by a individual with unspecified qualification from Brazil on 2011-12-29
Patient: male, weighing 26.0 kg (57.2 pounds)
Reactions: Nasopharyngitis, Dyspnoea, Cardiopulmonary Failure, Tachycardia, Hypertension, Oxygen Saturation Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Naglazyme
Other drugs received by patient: Unspecified Corticoids
|
